IMSMP signs a lease for additional 48,000 square feet to expand its facility

NewsGuard 100/100 Score

Lease for Additional 48,000 Square Feet Makes MS Research and Treatment Center Largest in the World

The International Multiple Sclerosis Management Practice (IMSMP), a 34,000 square foot research and treatment center dedicated to MS, today announced that it has signed a lease for an additional 48,000 square feet.  This makes it the largest establishment in the world committed to discovering the cause and cure for MS.

The practice expansion will include a Wellness Center and two MRI machines, while the Research Center will expand to include a Stem Cell Research Complex and Experimental Disease Model Facility. Dr. Saud A. Sadiq serves as the IMSMP's Director.  Under his vision, researchers and clinicians work side by side translating bench research into the best clinical care in the world.

"In light of the limited leasing activity experienced in 2009, the consummation of this lease represents one of the more notable leasing transactions for the year," said Scott Vetri, currently a partner at Katten, Muchin, Rosenman, LLP.

"Our ability to make such a bold move in these times of economic uncertainty is a testament to our fundraising, deep philanthropic appreciation, and our drive to care and cure our valued patients," said Dr. Saud A. Sadiq.

Construction is scheduled to begin July, 2010.  

SOURCE International Multiple Sclerosis Management Practice

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies